Tag: entrepreneurs
-
Cell, mRNA Therapy Biotech Raises $165M in Early Funds
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body.
-
Industry-Univ. Team Assessing Electronic Brain Biomarkers
A developer of software analyzing brain signals for neurological disease indicators is engaging medical researchers to help assess the software in real-world settings.
-
Venture to Build Cell, Gene Therapy Businesses
A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs.
-
Level Up As An Entrepreneur
As a start-up or a small company, it is nearly impossible to do anything in the business world in isolation.
-
Biotech Business Complex Slated for Colorado
A developer backed by a life science/real estate joint venture announced plans to create a new campus for biotechnology and related businesses in Boulder, Colorado.
-
Cannabinoid Synthesis Process Licensed to Spin-Off Company
A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process.
-
Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds
A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds.
-
Univ. Labs Ink Licensing Deals for Covid-19 Tests
Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections.
-
Immune Disease Biotech Acquired in $405M Deal
A biotechnology developer of treatments for autoimmune disorders with checkpoint receptor proteins is acquired by drug maker Gilead Sciences.
-
Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M
A new biotechnology company demonstrated in lab mice its therapy for glioblastoma, an aggressive brain cancer, that overcomes limitations of current treatments.